Nature Communications · 2023 · 12 citations · 43 references
Limited numbers of available hematopoietic stem cells (HSCs) limit the widespread use of HSC-based therapies. Expansion systems for functional heterogenous HSCs remain to be optimized. Here, we present a convenient strategy for human HSC expansion based on a biomimetic Microniche. After demonstrating the expansion of HSC from different sources, we find that our Microniche-based system expands the therapeutically attractive megakaryocyte-biased HSC. We demonstrate scalable HSC expansion by applying this strategy in a stirred bioreactor. Moreover, we identify that the functional human megakaryocyte-biased HSCs are enriched in the CD34<sup>+</sup>CD38<sup>-</sup>CD45RA-CD90<sup>+</sup>CD49f <sup>low</sup>CD62L<sup>-</sup>CD133<sup>+</sup> subpopulation. Specifically, the expansion of megakaryocyte-biased HSCs is supported by a biomimetic niche-like microenvironment, which generates a suitable cytokine milieu and supplies the appropriate physical scaffolding. Thus, beyond clarifying the existence and immuno-phenotype of human megakaryocyte-biased HSC, our study demonstrates a flexible human HSC expansion strategy that could help realize the strong clinical promise of HSC-based therapies.
43
REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms
Fran Supek, Matko Bošnjak, Nives Škunca et al. · PLoS ONE · 2011 · 6.7K citations · Full text
Single-cell reconstruction of the early maternal–fetal interface in humans
Roser Vento‐Tormo, Mirjana Efremova, Rachel A. Botting et al. · Nature · 2018 · 2.4K citations · Full text
CellMarker: a manually curated resource of cell markers in human and mouse
Xinxin Zhang, Yujia Lan, Jinyuan Xu et al. · Nucleic Acids Research · 2018 · 1.7K citations · Full text
Immunology, Pathology, Multiomics +21